Man Group PLC Alkermes Plc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Alkermes Plc. stock. As of the latest transaction made, Man Group PLC holds 228,557 shares of ALKS stock, worth $6.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

228,557

Previous 516,831 55.78%

Holding current value

$6.58 Million

Previous $12.5 Million 48.64%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $6.63 Million - $8.23 Million	-288,274 Reduced 55.78%	228,557 $6.4 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $8.28 Million - $9.72 Million	-356,802 Reduced 40.84%	516,831 $12.5 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $1.39 Million - $1.71 Million	-52,556 Reduced 5.67%	873,633 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $9.31 Million - $11.4 Million	398,391 Added 75.48%	926,189 $25.7 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $13.8 Million - $16.2 Million	507,569 Added 2509.12%	527,798 $14.8 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $560,650 - $665,302	-19,783 Reduced 49.44%	20,229 $633,000
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $6.67 Million - $7.65 Million	-263,639 Reduced 86.82%	40,012 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $2.44 Million - $2.92 Million	111,243 Added 57.82%	303,651 $7.93 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $1.92 Million - $2.78 Million	-87,317 Reduced 31.22%	192,408 $4.3 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $5.02 Million - $5.81 Million	190,165 Added 212.33%	279,725 $8.33 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $206,015 - $249,950	8,930 Added 11.08%	89,560 $2.36 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $303,650 - $453,707	-14,143 Reduced 14.92%	80,630 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $945,339 - $1.3 Million	40,451 Added 74.47%	94,773 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $4.26 Million - $5.71 Million	-226,897 Reduced 80.68%	54,322 $1.33 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $265,647 - $338,441	-14,588 Reduced 4.93%	281,219 $5.25 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $965,891 - $1.39 Million	-62,761 Reduced 17.5%	295,807 $5.9 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $4.58 Million - $5.86 Million	283,419 Added 377.14%	358,568 $5.94 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $640,437 - $933,950	-48,117 Reduced 39.04%	75,149 $1.46 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $1.78 Million - $2.9 Million	-136,379 Reduced 52.53%	123,266 $1.78 Million
Q4 2019 Feb 18, 2020	BUY	$17.29 - $21.74 $2.42 Million - $3.04 Million	140,064 Added 117.13%	259,645 $5.3 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $160,664 - $199,945	8,235 Added 7.4%	119,581 $2.33 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $2.25 Million - $3.91 Million	104,755 Added 1589.36%	111,346 $2.51 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $33,682 - $43,277	-1,186 Reduced 15.25%	6,591 $240,000
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $2.05 Million - $3.28 Million	-73,500 Reduced 90.43%	7,777 $229,000
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $2.3 Million - $2.74 Million	59,491 Added 273.07%	81,277 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $573,356 - $726,024	14,136 Added 184.78%	21,786 $897,000
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $410,116 - $514,539	7,650 New	7,650 $443,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account